Therapeutic drug monitoring tests measure the amount of selected medicines or medicine-related compounds in blood, including lithium, tacrolimus, sirolimus, carbamazepine, and valproic acid. Shoppers often compare these options when a prescriber wants to follow a known medication level, distinguish total from free drug, or assess carbamazepine alongside its 10,11-epoxide metabolite. The useful next step is to match the ordered test to the medication name and the specific measurement requested, then review the result with the professional managing that medication.
Match the reported form to the clinical question
A total drug result reflects the overall amount measured in the sample, while a free result refers to the unbound portion named by the test. That distinction is built into Valproic Acid, Total and Free and Carbamazepine and Metabolite, Free/Bound/Total. For carbamazepine, the latter also reports bound carbamazepine and carbamazepine-10,11-epoxide, a named metabolite. A request for Carbamazepine, Total answers a different measurement question than an order that includes free, bound, total, and metabolite values. Use the wording on the laboratory order to select the same form of measurement requested by the clinician overseeing care.
Why timing and professional review matter
Medication concentrations are interpreted against the dose schedule, the timing of the blood draw, the reason for monitoring, and prior results. A number alone does not establish whether treatment is appropriate or explain symptoms. Lithium, Tacrolimus, Highly Sensitive, LC/MS/MS, and Sirolimus, LC/MS/MS each measure the specifically named medication, whereas Tacrolimus and Sirolimus, LC/MS/MS measures both named medications together. Record when the sample was collected in relation to the medication schedule if your care team asks for that information. Contact the professional managing the medication for interpretation, especially if symptoms or an unexpected result are involved.